换一批
换一批Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
作者：
J,Keyl [1]
;
A,Bucher [2]
;
F,Jungmann [3]
;
R,Hosch [4]
;
A,Ziller [3]
;
R,Armbruster [5]
;
P,Malkomes [6]
;
T M,Reissig [7]
;
S,Koitka [8]
;
I,Tzianopoulos [9]
;
P,Keyl [10]
;
K,Kostbade [11]
;
D,Albers [12]
;
P,Markus [13]
;
J,Treckmann [14]
;
K,Nassenstein [15]
;
J,Haubold [15]
;
M,Makowski [16]
;
M,Forsting [17]
;
H A,Baba [18]
;
S,Kasper [19]
;
J T,Siveke [20]
;
F,Nensa [21]
;
M,Schuler [22]
;
G,Kaissis [3]
;
J,Kleesiek [23]
;
R,Braren [24]
作者单位：
Institute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany; Institute of Pathology, University Hospital Essen (AöR), Essen, Germany. Electronic address: Julius.Keyl@uk-essen.de.
[1]
Institute for Diagnostic and Interventional Radiology, Goethe University Frankfurt, Frankfurt am Main, Germany; German Cancer Consortium (DKTK), Frankfurt partner site, Heidelberg, Germany.
[2]
Institute of Diagnostic and Interventional Radiology, Technical University of Munich, School of Medicine, Munich, Germany; Artificial Intelligence in Healthcare and Medicine, School of Computation, Information and Technology, Technical University of Munich, Munich, Germany.
[3]
Institute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.
[4]
Institute for Diagnostic and Interventional Radiology, Goethe University Frankfurt, Frankfurt am Main, Germany.
[5]
Department of General, Visceral and Transplant Surgery, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany.
[6]
Department of Medical Oncology, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
[7]
Institute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany; Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen (AöR), Essen, Germany.
[8]
Department of Medical Oncology, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany.
[9]
Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.
[10]
Department of Medical Oncology, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[11]
Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
[12]
Department of General Surgery and Traumatology, Elisabeth Hospital Essen, Essen, Germany.
[13]
West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany; Department of General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany.
[14]
Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[15]
Institute of Diagnostic and Interventional Radiology, Technical University of Munich, School of Medicine, Munich, Germany.
[16]
German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[17]
Institute of Pathology, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[18]
Department of Medical Oncology, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[19]
Department of Medical Oncology, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[20]
Institute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[21]
Department of Medical Oncology, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany; National Center for Tumor Diseases (NCT), NCT West, Essen, Germany.
[22]
Institute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany; West German Cancer Center, University Hospital Essen (AöR), Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[23]
Institute of Diagnostic and Interventional Radiology, Technical University of Munich, School of Medicine, Munich, Germany; German Cancer Consortium (DKTK), Munich partner site, Heidelberg, Germany.
[24]
主题词
人类(Humans);预后(Prognosis);肌减少症(Sarcopenia);肌, 骨骼(Muscle, Skeletal);回顾性研究(Retrospective Studies);身体成分(Body Composition);胰腺肿瘤(Pancreatic Neoplasms)
DOI
10.1016/j.esmoop.2023.102219
PMID
38194881
发布时间
2024-02-07
- 浏览0
ESMO open
ESMO open
2024年9卷1期
102219页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
